Inflammation in neurodegenerative disease—a double-edged sword

T Wyss-Coray, L Mucke - Neuron, 2002 - cell.com
Inflammation is a defense reaction against diverse insults, designed to remove noxious
agents and to inhibit their detrimental effects. It consists of a dazzling array of molecular and …

Complement components of the innate immune system in health and disease in the CNS

P Gasque, YD Dean, EP McGreal, J VanBeek… - …, 2000 - Elsevier
The innate immune system and notably the complement (C) system play important roles in
host defense to recognise and kill deleterious invaders or toxic entities, but activation at …

Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis

C Lock, G Hermans, R Pedotti, A Brendolan… - Nature medicine, 2002 - nature.com
Microarray analysis of multiple sclerosis (MS) lesions obtained at autopsy revealed
increased transcripts of genes encoding inflammatory cytokines, particularly interleukin-6 …

Prominent neurodegeneration and increased plaque formation in complement-inhibited Alzheimer's mice

T Wyss-Coray, F Yan, AHT Lin… - Proceedings of the …, 2002 - National Acad Sciences
Abnormal accumulation of β-amyloid (Aβ) in Alzheimer's disease (AD) is associated with
prominent brain inflammation. Whereas earlier studies concluded that this inflammation is …

T‐and B‐cell responses to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis and multiple sclerosis

A Iglesias, J Bauer, T Litzenburger, A Schubart… - Glia, 2001 - Wiley Online Library
The identification of myelin oligodendrocyte glycoprotein (MOG) as a target for autoantibody‐
mediated demyelination in experimental autoimmune encephalomyelitis (EAE) resulted in …

The spectrum of complement alternative pathway‐mediated diseases

VM Holers - Immunological reviews, 2008 - Wiley Online Library
The complement system has once again come into prominence in the therapeutic
development arena. The recent approval of an inhibitory monoclonal antibody, eculizumab …

Inhibition of complement C3 signaling ameliorates locomotor and visual dysfunction in autoimmune inflammatory diseases

L Xu, H Xu, S Chen, W Jiang, SK Afridi, Y Wang… - Molecular Therapy, 2023 - cell.com
Neuromyelitis optica (NMO) is an autoimmune inflammatory disease of the central nervous
system (CNS) characterized by transverse myelitis and optic neuritis. The pathogenic serum …

Complement C3-targeted gene therapy restricts onset and progression of neurodegeneration in chronic mouse glaucoma

A Bosco, SR Anderson, KT Breen, CO Romero… - Molecular Therapy, 2018 - cell.com
Dysregulation of the complement system is implicated in neurodegeneration, including
human and animal glaucoma. Optic nerve and retinal damage in glaucoma is preceded by …

B cells and antibodies in CNS demyelinating disease

AH Cross, JL Trotter, JA Lyons - Journal of neuroimmunology, 2001 - Elsevier
There is much evidence to implicate B cells, plasma cells, and their products in the
pathogenesis of MS. Despite unequivocal evidence that the animal model for MS, EAE, is …

Brain microglia and blood-derived macrophages: molecular profiles and functional roles in multiple sclerosis and animal models of autoimmune demyelinating …

G Raivich, R Banati - Brain Research Reviews, 2004 - Elsevier
Microglia and macrophages, one a brain-resident, the other a mostly hematogenous cell
type, represent two related cell types involved in the brain pathology in multiple sclerosis …